Zorion Medical develops a breakthrough device platform that utilizes unique and proprietary biomaterials that can be absorbed into the cardiovascular system in 3 to 6 months following delivery. Their vision is to treat the problem of coronary or peripheral artery disease by deploying the device, delivering the drug, and disappearing as soon as the body has healed itself, eliminating the need for further treatment and the potential for other complications.